Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Biovail Announces Closing of Acquisition of Worldwide Rights to Tetrabenazine
BioVail Corporation, 06/23/09

Biovail Corporation announced that a wholly owned subsidiary has completed the acquisition of the worldwide development and commercialization rights to the entire portfolio of tetrabenazine products, including Xenazine/Nitoman, and the associated intellectual property rights held by Cambridge Laboratories Limited and its affiliates.


Today in Regulatory Issues...keeping you current

Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09

Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09

New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09

See All of Regulatory Issues

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address